Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve low-yield quinoline synthesis challenges with this silver triflate method. Achieve 94%+ yields, 99.9% purity, and simplified purification for drug development.
Solve high-toxicity reagent risks and multi-step costs in pyridine intermediate synthesis. New one-step method boosts yield to 87.5% with 97.5% purity, reducing solvent use and scaling challenges.
Solve low-yield issues in diphenylacetonitrile production with this 90%+ yield, low-toxicity method. Reduce costs and environmental risks for your API supply chain.
Solve 4-substituted isocoumarin synthesis challenges with metal-free, scalable route. 70-90% yields, no metal ions, ideal for API production. Contact us for custom synthesis.
Reduce production costs and metal residues with this efficient photocatalytic route for high-purity o-amino aromatic ketones in drug development.
Discover how metal-free carbonyl-bridged biheterocyclic synthesis eliminates CO gas hazards, reduces costs, and enables scalable production for pharmaceutical intermediates.
Discover N-N axis chiral indole-pyrrole synthesis with 97% ee, reducing R&D costs and supply chain risks for asymmetric pharmaceutical catalysts.
Discover a scalable, high-ee synthesis method for N-N axis chiral indole-pyrrole compounds. Ideal for chiral catalyst development with 97% ee and 62% yield. Reduce R&D costs and supply chain risks.
Solve chiral synthesis challenges with metal-free helicene production. 99% ee, 68% yield. Reduce costs & supply risks for asymmetric catalysis.
Discover how visible light photocatalysis enables 90% yield in fluoroalkyl heterocycle synthesis, eliminating high-pressure equipment and reducing supply chain risks for pharmaceutical intermediates.
Discover how chiral phase transfer catalysis enables 92% ee and 80% yield in axial chiral isopyrone-indole synthesis for potent PC-3 tumor activity. Scale-ready for pharma R&D.
Discover scalable ruthenium-catalyzed N-acylpyrrole synthesis with 80% yield. Reduce costs and supply chain risks for pharma R&D and procurement with simplified industrial processes.
Reduce production costs and avoid moisture-sensitive steps with this zirconium-based amide synthesis method. Ideal for pharmaceutical intermediates and large-scale manufacturing.
Discover how novel nintedanib synthesis routes with 92% yield and mild conditions reduce production costs by 30% while ensuring GMP compliance for IPF treatment.
Solve supply chain risks with air-stable, metal-free synthesis of trifluoroacetimide dihydrobenzofuran. High stereoselectivity, low cost, and scalable to 100MT/yr.
Solve piperazine cyanation challenges with metal-free visible light catalysis. 83% yield, air atmosphere, no expensive equipment. Scale to 100MT/yr.
Discover how metal-free catalysis in pyrazolopyrimidine synthesis reduces costs and improves scalability for pharmaceutical production.
Solve low-yield benzoindolizine synthesis with metal-free [3+2] cycloaddition. Achieve 85%+ yields, eliminate transition metal risks, and scale to 100 MT/yr. Contact for COA/MSDS.
Solve high-cost catalysts & harsh conditions in benzothiazole synthesis. New CO2-based method achieves 85.9% yield at 80°C. Contact for CDMO solutions.
Discover a metal-free, high-yield synthesis method for sulfonylated indolo[1,2-a]quinoline compounds. Reduce production costs and safety risks in pharmaceutical manufacturing.